C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice

Renal Failure

Volumn 34, Issue 7, 2012, Pages 892-900

  Lim, Beom Jin ^a   Jeong, Jin Young ^a   Chang, Yoon Kyung ^b   Na, Ki Ryang ^a   Lee, Kang Wook ^a   Shin, Young Tai ^a   Choi, Dae Eun ^a  

^a Chungnam National University College of Medicine   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

apoptosis; C phycocyanin; cisplatin induced nephrotoxicity

Indexed keywords

C PHYCOCYANIN; CASPASE 3; CASPASE 9; CISPLATIN; CREATININE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHYCOCYANIN; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CISPLATIN; IN SITU NICK-END LABELING; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; PHYCOCYANIN;

EID: 84863864205     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.690925     Document Type: Article

References (33)

1. Jones BR, Bhalla RB, Mladek J, et al. Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther. 1980;27(4):557-562. (Pubitemid 10099074)
2. Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis. 1986;8(5):368-379. (Pubitemid 17235084)
3. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: A review. Am J Med Sci. 2007;334(2):115-124. (Pubitemid 47262919)
4. Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats. Toxicology. 1989;59(2):151-162. (Pubitemid 19270043)
5. Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol. 2004;287(3):F543-F549. (Pubitemid 39095970)
6. Jo SK, Cho WY, Sung SA, Kim HK, Won NH. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005;67(2):458-466. (Pubitemid 40139837)
7. Francescato HD, Costa RS, Da Silva CG, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sci. 2009;84(17-18):590-597.
8. Francescato HD, Costa RS, Junior FB, Coimbra TM. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant. 2007;22(8):2138-2148. (Pubitemid 47244690)
9. Luo J, Tsuji T, Yasuda H, et al. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23(7):2198-2205. (Pubitemid 351957613)
10. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med. 2004;8(4):445-454.
11. Tsuruya K,Ninomiya T, TokumotoM, et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int. 2003;63(1):72-82. (Pubitemid 35463908)
12. Lissi EA, Pizarro M, Aspee A, Romay C. Kinetics of phycocyanine bilin groups destruction by peroxyl radicals. Free Radic Biol Med. 2000;28(7):1051-1055. (Pubitemid 30314703)
13. Romay C, Armesto J, Remirez D, et al. Antioxidant and antiinflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res. 1998;47(1):36-41. (Pubitemid 28048114)
14. Khan M, Varadharaj S, Ganesan LP, et al. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol. 2006;290(5):H2136-H2145.
15. Farooq SM, Asokan D, Sakthivel R, Kalaiselvi P, Varalakshmi P. Salubrious effect of C-phycocyanin against oxalate-mediated renal cell injury. Clin Chim Acta. 2004;348(1-2):199-205. (Pubitemid 39209020)
16. Lee KW, Jeong JY, Lim BJ, et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology. 2009;257(3):137-143.
17. Choi DE, Jeong JY, Lim BJ, et al. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am J Physiol Renal Physiol. 2009;297(2):F362-F370.
18. Li XL, Xu G, Chen T, et al. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-nduced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways. Int J Biochem Cell Biol. 2009;41(7):1526-1535.
19. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol. 2004;18(1):37-52. (Pubitemid 38949985)
20. Kang DG, Lee AS, Mun YJ, et al. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull. 2004;27(3):366-370. (Pubitemid 41685481)
21. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005;365(9457):417-430. (Pubitemid 40179230)
22. Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology. 2007;230(1):64-75. (Pubitemid 46084872)
23. Iseri S, Ercan F, Gedik N, Yuksel M, Alican I. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology. 2007;230(2-3):256-264. (Pubitemid 46109145)
24. Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S. Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat. 2005;8(1-2):5-14. (Pubitemid 40797952)
25. Faubel S, Ljubanovic D, Reznikov L, et al. Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis. Kidney Int. 2004;66(6):2202-2213. (Pubitemid 41115283)
26. Wei Q, Dong G, Franklin J, Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int. 2007;72(1):53-62. (Pubitemid 47014446)
27. Jiang M, Wang CY, Huang S, Yang T, Dong Z. Cisplatin-nduced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am J Physiol Renal Physiol. 2009;296(5):F983-F993.
28. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int. 2001;60(5):1726-1736. (Pubitemid 32999977)
29. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem. 2000;275(50):39435-39443. (Pubitemid 32058968)
30. Sanchez-Perez I, Murguia JR, Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene. 1998;16(4):533-540. (Pubitemid 28062081)
31. Persons DL, Yazlovitskaya EM, Cui W, Pelling JC. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res. 1999;5(5):1007-1014. (Pubitemid 29233214)
32. Ramesh G, Kimball SR, Jefferson LS, Reeves WB. Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells. Am J Physiol Renal Physiol. 2007;292(2):F812-F819. (Pubitemid 46220550)
33. Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 2005;289(1):F166-F174. (Pubitemid 40863584)